{"id":339191,"date":"2026-11-04T14:04:39","date_gmt":"2026-11-04T08:34:39","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=339191"},"modified":"2026-11-04T14:04:39","modified_gmt":"2026-11-04T08:34:39","slug":"largecap-fii-backed-quarterly-sales-growth-stocks-to-watch-multibagger-potential","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/largecap-fii-backed-quarterly-sales-growth-stocks-to-watch-multibagger-potential\/","title":{"rendered":"4 Largecap FII Backed Quarterly Sales Growth Stocks to Watch for Future Multibagger Potential: Titan, Divi’s Labs, Apollo Hospitals and HDFC Life"},"content":{"rendered":"

Titan Rs 4,562. Divi’s Labs Rs 10,064. Apollo Hospitals Rs 8,440. HDFC Life Rs 525.50. Market caps from Rs 1.14 lakh crore to Rs 4.14 lakh crore. Data as of 3 Nov 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Titan, Divi’s Labs, Apollo Hospitals and HDFC Life are the 4 picks in this FII backed quarterly sales growth stocks watchlist, with market caps between Rs 1.14 lakh crore and Rs 4.14 lakh crore. Titan stands out for the highest return on equity at 32.31%, while Divi’s Labs offers the strongest latest-quarter profit growth at 65.50%. PE ratios run from 57.61 to 90.13, so compare each one with its industry PE before investing. All figures are as of 3 November 2026.<\/p>\n<\/p><\/div>\n

FII backed quarterly sales growth stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Titan, Divi’s Labs, Apollo Hospitals and HDFC Life meet that test, with market caps from Rs 1.14 lakh crore to Rs 4.14 lakh crore and Titan offering the highest return on equity at 32.31%. Each of these companies has a foreign institutional holding of at least 15 per cent and latest quarter revenue growth of at least 15 per cent year on year, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.<\/p>\n

This list covers companies with a foreign institutional holding of at least 15 per cent and latest quarter revenue growth of at least 15 per cent year on year, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening FII backed quarterly sales growth stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 3 November 2026 and are drawn from NSE and BSE data and company filings.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n